Search filters

List of works by Larry W Kwak

90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease

scientific article

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

scientific article

A novel proteoliposomal vaccine elicits potent antitumor immunity in mice

scientific article published on 9 March 2007

A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma

scientific article

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

scientific article published on 09 May 2019

Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma

scientific article published on 2 November 2011

Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion

scientific article published on February 2004

American Journal of Blood Research: Editorial Board (2011) e-Century Publishing Corporation ⬇️

scientific article published on June 13, 2011

Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy

scientific article published in April 2015

Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells

scientific article published on 8 June 2006

Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes

scientific article

B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis

scientific article published on 17 February 2005

Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression

scientific article

Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma ⬇️

scientific article published on October 21, 2011

CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies

scientific article published on 01 September 2019

CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma

scientific article

Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities

scientific article published on 31 January 2012

Cancer Vaccines: Moving toward Prevention? ⬇️

scientific article published on July 1, 2011

Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo

scientific article published on 10 June 2004

Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera

scientific article

Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma ⬇️

scientific article published on March 19, 2012

Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach

scientific article published on 29 March 2015

Development of Vaccine Strategies for the Treatment of B-Cell Malignancies ⬇️

scientific article published on January 1, 1997

Double hit lymphoma: the MD Anderson Cancer Center clinical experience.

scientific article

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

scientific article

Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma

scientific article published on 27 March 2015

Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice

scientific article

Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccines ⬇️

scientific article published on November 23, 2010

Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis

scientific article published on 9 April 2004

Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis

scientific article

Idiotype Vaccination As Consolidation Therapy: Time for Integration Into Standard of Care for Follicular Lymphoma? ⬇️

scientific article published on October 31, 2011

Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.

scientific article

Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial

scientific article

Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma

scientific article

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

scientific article

Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma

scientific article published on 28 February 2019

Lymphoma Vaccine Therapy: Next Steps After a Positive, Controlled Phase III Clinical Trial ⬇️

scientific article published on June 1, 2012

MACOP-B ± radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford Results According to Prognostic Indices ⬇️

scientific article published on June 15, 1993

Mammalian defensins in immunity: more than just microbicidal

scientific article

MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response

scientific article

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients ⬇️

scientific article published on July 9, 2012

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone

scientific article

Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma

scientific article

Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells

scientific article published on 17 August 2006

Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry

scientific article

PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma ⬇️

scientific article published on September 21, 2012

Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial

scientific article

Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.

scientific article published on 31 March 2015

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma

scientific article

Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.

scientific article published on 3 May 2018

Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma

scientific article

Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma.

scientific article

Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes

scientific article

Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma

scientific article published on 26 April 2011

Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma

scientific article

Phase I trial of bortezomib in combination with rituximab‐HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma ⬇️

scientific article published on August 5, 2010

Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma

scientific article

Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma

scientific article published on 27 July 2015

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.

scientific article published in June 2007

Prime-boost vaccination using chemokine-fused gp120 DNA and HIV envelope peptides activates both immediate and long-term memory cellular responses in rhesus macaques

scientific article

Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.

scientific article

Prospective isolation of clonogenic mantle cell lymphoma-initiating cells

scientific article

Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma

scientific article published on October 2013

Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center

scientific article

Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells ⬇️

scientific article published on September 11, 2012

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

scientific article

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

scientific article

Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma

scientific article

Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray

scientific article

T cells and T cell tumors efficiently generate antigen-specific cytotoxic T cell immunity when modified with an NKT ligand ⬇️

scientific article published on March 1, 2012

TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas

scientific article

Targeting cell surface β2 -microglobulin by pentameric IgM antibodies

scientific article

The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma

scientific article published on 06 January 2014

Therapeutic idiotype vaccines in B lymphoproliferative diseases

scientific article published on June 2004

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

scientific article

Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes

scientific article

Translational development of active immunotherapy for hematologic malignancies

scientific article

Translational development of vaccination strategies in follicular NHL ⬇️

scientific article published on 06 May 2011

Tumor vaccination strategies combined with autologous peripheral stem cell transplantation ⬇️

scientific article published on January 1, 1998

Vaccination strategies for lymphomas

scientific article

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma

scientific article

Verapamil synergistically enhances cytotoxicity of bortezomib in mantle cell lymphoma via induction of reactive oxygen species production ⬇️

scientific article published on August 24, 2012

Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial

scientific article published on 29 December 2012

Paulina is supported by:

About Paulina

Help